title: [Antibiotic prophylaxis in colon surgery: cefazolin (Kefzol- ornidazole (Tiberal) versus cephazolin-placebo].
abstract: A prospective, randomized, double-blind and controlled clinical trial of systemic antibiotic prophylaxis with Cefazolin and Ornidazol (CO) versus Cefazolin and Placebo (CP) was carried out consecutively in 100 patients undergoing elective, colorectal surgery. The incidence of wound infection in the CP-group was 20% (n = 10) and in the CO-group 8% (n = 4) (p less than 0.10 ns). The reduction of anaerobic bacterias from 20% (n = 10) in the CP-group to 0% (n = 0) (CO) was significant (a1 = 0.0139; a2 = 0.0277 s, Fischer's exact test). The time of hospitalization was reduced from 20.3 days (CP) to 16.7 days (CO) (p less than 0.05 s). The agent for antibiotic prophylaxis in elective colorectal surgery is to cover the spectrum of anaerobic bacterias.
authors.forename: M
authors.initials: M
authors.lastname: Zuber
authors.forename: M
authors.initials: M
authors.lastname: Dürig
authors.forename: U
authors.initials: U
authors.lastname: Neff
authors.forename: U
authors.initials: U
authors.lastname: Laffer
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002437:Cefazolin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003106:Colon / Q000601:surgery; D004311:Double-Blind Method; D006801:Humans; D007902:Length of Stay; D008875:Middle Aged; D009593:Nitroimidazoles / Q000627:therapeutic use*; D009950:Ornidazole / Q000627:therapeutic use*; D011292:Premedication; D011446:Prospective Studies; D011897:Random Allocation; D012007:Rectum / Q000601:surgery; D013530:Surgical Wound Infection / Q000517:prevention & control*
chemical_list: D009593:Nitroimidazoles; D009950:Ornidazole; D002437:Cefazolin
vernacular_title: Antibiotikaprophylaxe in der Kolonchirurgie: Cefazolin (Kefzol)-Ornidazol (Tiberal) versus Cefazolin-Placebo.